Victoria Clements, MPH, is the Director of Operations at Coriell Life Sciences. In this role, Victoria is responsible for overall strategic product and process development, vendor relations, and cross-department support to ensure optimal program and product delivery and service. Along with her team, Victoria focuses on full program execution and ongoing support, patient and clinical support, reporting oversight, program efficiency, and customer success.
At Coriell Life Sciences, Victoria combines her passion for public health and genomics through Corigen, the company’s medication risk management program, which combines pharmacogenomics information with traditional medication therapy management to optimize safe and effective drug regimens that improve patient quality of life, decrease healthcare spend, reduce health incidents, and enhance the clinician experience.
Prior to this position, Victoria worked at the Coriell Institute for Medical Research, a biomedical research institution dedicated to the study of the human genome. Victoria worked on the Coriell Personalized Medicine Collaborative’s $10 million-dollar genomic utility research contract with the United States Air Force where she led participant engagement and joined the scientific team to develop disease- and medication-specific genetic risk reports.
In addition to personalized medicine, Victoria oversaw the Institute’s development initiatives to expand research capacity by pinpointing funding opportunities aligned with the organization’s priorities, coordinating proposal development, and identifying prospective collaborators.
Victoria has dedicated her career and academic interests to public health genomics by leveraging advances in science and technology that make genetic information accessible to clinicians and patients as part of everyday care.
Victoria earned her Master of Public Health degree from Drexel University where her scholarship focused on public health genomics. She received her undergraduate degree in biology from Rowan University.